Abstract
Introduction: Endothelial nitric oxide synthase (ecNOS) is a key regulator of vascular nitric oxide production. Polymorphism in intron 4 of the ecNOS gene is implicated in cardiovascular and renal diseases. We investigated a potential involvement of this polymorphism in the development of type 2 diabetes mellitus and its renal complications.
Methods: This preliminary study involved 410 individuals with type 2 diabetes and 330 healthy control subjects. From the diabetes group 178 patients had diabetic nephropathy. All subjects were genotyped for the ecNOS4 polymorphism by the polymerase chain reaction (PCR) followed by gel electrophoresis. Genotype and allele frequencies were compared between diabetes patients with and without nephropathy and the control group. All calculations were performed using the Statistical Package for the Social Sciences (SPSS, Inc., Chicago, IL, USA) for Windows 5.0. The chi-square test and Fisher’s exact test were used for case-control comparisons. The Kruskal-Wallis test was used for the comparison of subgroups of patients with diabetes.
Results: The analysis revealed that patients with diabetes, regardless of their nephropathy status, were significantly different in genotype distribution and 4a allele frequencies compared with controls (p < 0.05). The frequency of aa genotype was 8.2% in diabetic patients without nephropathy, 8.4% with those with nephropathy and 1.2% in controls. The 4a allele showed a significant effect on diabetic nephropathy, with odds ratio of 2.24 (95% confidence interval 1.12–3.40). There were no significant differences in the 4a allele frequency between the normotensive and hypertensive patients with diabetes.
Conclusion: Our results suggest that the ecNOS gene polymorphism can serve as a useful genetic marker of increased susceptibility to type 2 diabetes and its renal complications.
Similar content being viewed by others
References
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–12
Schmidt HH, Walter U. NO at work. Cell 1994 Sep; 78(6): 919–25
Hayden MR, Tyagi SC. Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation?: the role of NOS, NO, and redox stress. Cardiovasc Diabetol 2003 Feb 12; 2(1): 2
Rudic RD, Sessa WC. Nitric oxide in endothelial dysfunction and vascular remodeling: clinical correlates and experimental links. Am J Hum Genet 1999 Mar; 64(4): 673–7
Tolins JP, Palmer RM, Moncada S, et al. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990 Mar; 258 (3 Pt 2): 655–62
Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000 Aug; 70(4): 241–51
Nadaud S, Bonnardeaux A, Lathrop M, et al. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994 Feb 15; 198(3): 1027–33
Wang XL, Sim AS, Badenhop RF, et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996 Jan; 2(1): 41–5
Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998 Jul; 32(1): 3–8
Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998 Sep; 32(3): 521–6
Komatsu M, Kawagishi T, Emoto M, et al. ecNOS gene polymorphism is associated with endothelium dependent vasodilation in type 2 diabetes. Am J Physiol Heart Circ Physiol 2002 Aug; 283(2): H557–61
Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes 1998 Mar; 47(3): 457–63
The Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 Suppl. 1: S5–22
Madisen L, Hoar LD, Holroyd CD, et al. DNA banking: the effect of storage of blood and isolated DNA on integrity of DNA. Am J Med Genet 1987 Jun; 27(2): 379–90
DeMattia G, Laurenti O, Fava D. Diabetic endothelial dysfunction: effect of free radical scavenging in type 2 diabetic patients. J Diabetes Complications 2003 Mar–Apr; 17 Suppl. 2: 30–5
Fava S, Hattersley AT. The role of genetic susceptibility in diabetic nephropathy: evidence from family studies. Nephrol Dial Transplant 2002 Sep; 17(9): 1543–6
Neugebauer S, Baba T, Watanabe T. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000 Mar; 49(3): 500–3
Zanchi A, Moczulski DK, Hanna LS, et al. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000 Feb; 57(2): 405–13
Asakimori Y, Noriaki Y, Yamamoto Y, et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron 2001 Oct; 89(2): 219–23
Shimizu T, Onuma T, Kawamori R, et al. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 2002 Dec; 58(3): 179–85
Rogus JJ, Warram JH, Krolewski AS. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 2002 Jun; 51(6): 1655–62
Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998 Apr 7; 245(1): 190–3
McCance DR, Hunson RL, Pettitt DJ, et al. Diabetic nephropathy: a risk factor for diabetes mellitus in offspring. Diabetologia 1995 Feb; 38(2): 221–6
Acknowledgements
This work was supported by University Medical School in Lublin grants DS.233/02 and DS.235/02. The authors have provided no information on conflicts of interest directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ksiazek, P., Wojewoda, P., Muc, K. et al. Endothelial Nitric Oxide Synthase Gene Intron 4 Polymorphism in Type 2 Diabetes Mellitus. CNS Drugs 7, 119–123 (2003). https://doi.org/10.1007/BF03260027
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03260027